NDC product
Aftera
NDC 69536-103 · Foundation Consumer Healthcare LLC
Key facts
| Product NDC | 69536-103 |
|---|---|
| Proprietary name | Aftera |
| Nonproprietary name | LEVONORGESTREL |
| Substances | LEVONORGESTREL |
| Dosage form | TABLET |
| Route | ORAL |
| Labeler | Foundation Consumer Healthcare LLC |
| Product type | HUMAN OTC DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Application number | NDA021998 |
| Pharmacologic classes | Inhibit Ovum Fertilization [PE], Progesterone Congeners [CS], Progestin [EPC], Progestin-containing Intrauterine Device [EPC] |
| Marketing start | May 10, 2018 |
| Listing certified through | Dec 31, 2026 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: